1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses

OBJECTIVE: Actinic keratoses (AKs) are cutaneous lesions that arise in sun-damaged skin. AKs may transform into squamous cell carcinoma in situ. Tirbanibulin 1% ointment is a new topical treatment for AKs, recently approved by the Food and Drug Administration. DATA SOURCES: The PubMed database was s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dao, Diem-Phuong D., Sahni, Vikram Nath, Sahni, Dev Ram, Balogh, Esther A., Grada, Ayman, Feldman, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Article - New Drug Approval
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899810/
https://www.ncbi.nlm.nih.gov/pubmed/34301153
http://dx.doi.org/10.1177/10600280211031329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899810/
https://www.ncbi.nlm.nih.gov/pubmed/34301153
http://dx.doi.org/10.1177/10600280211031329

Ejemplares similares